Trial Information

Summary: Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

New York University Medical Center is currently conducting a research drug study to evaluate entecavir in subjects receiving liver transplant due to chronic hepatitis B virus infection.

You may be eligible to participate in this study if you:

  • Are at least 18 years of age
  • Orthotopic Liver Transplant (OLT) patients with end-stage liver disease due to chronic HBV infection.

You may not participate in this study if you:

  • Are pregnant, breastfeeding or intend to become pregnant during the study
  • Are a multi-organ or retransplant recipient
  • Have participated in another research study within the last 30 days

For more information,

Contact:

Christelle Sommervil, Study Coordinator
Biomedical Research Alliance of New York
New York University Medical Center
403 East 34th St 3rd Floor
New York, NY 10016
Telephone: 212-263-8391
Fax: 212-263-3601
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:42 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA